« BACK

Medicine/Pharmacology



Results 1 - 20 of 305.
1 2 3 4 5 ... 16 Next »

Medicine/Pharmacology - Innovation/Technology
19.02.2018
Taking blood without a needle
Taking blood without a needle
EPFL-based startup Loop Medical is working on a needleless device to take pain-free blood samples at home.
Medicine/Pharmacology - Life Sciences
19.02.2018
A therapeutic approach inspired by nature
A therapeutic approach inspired by nature
T3 Pharmaceuticals AG - a startup from the University of Basel - genetically modifies bacteria and wants to use this to develop new cancer therapies.
Medicine/Pharmacology
16.02.2018
Novartis new data show Cosentyx improved quality of life over 5 years in two thirds of patients with moderate to severe plaque psoriasis
Novartis new data show Cosentyx improved quality of life over 5 years in two thirds of patients with moderate to severe plaque psoriasis
Two thirds of patients on Cosentyx (secukinumab) reported no impact of skin disease on their quality of life over 5 years, SCULPTURE study shows   Findings show absolute PASI <=1/<=2/<=3 responses were sustained in those treated with Cosentyx from Year 1 to Year 5   Cosentyx is the first and only fully human interleukin-17A (IL-17A) inhibitor that showed sustained skin clearance rates at 5 years in patients from a psoriasis Phase III st
Medicine/Pharmacology - Innovation/Technology
15.02.2018
Improving Health of Children in Nigeria
Improving Health of Children in Nigeria
To improve diagnosis and treatment of children under five, Swiss TPH together with the International Committee of the Red Cross (ICRC) developed the electronic decision support tool ALMANACH.
Life Sciences - Medicine/Pharmacology
09.02.2018
Stem cell divisions in the adult brain seen for the first time
Stem cell divisions in the adult brain seen for the first time
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain can generate new nerve cells throughout life. One of the areas where this happens is the hippocampus, a brain structure that determines many types of learning and memory, deciding what is remembered and what is forgotten.
Environment/Sustainable Development - Medicine/Pharmacology
07.02.2018
Confirming the risks of pesticide use in Burkina Faso
Confirming the risks of pesticide use in Burkina Faso
Poor pesticide practices in Burkina Faso pose a threat to human health and the environment. An EPFL thesis has quantified this problem for the first time through an analysis of soil, water, sediment, vegetable and hair samples. Small-scale vegetable growers in Burkina Faso are unfamiliar with the proper use of pesticides and end up exposing both people and the environment to serious contamination risks.
Life Sciences - Medicine/Pharmacology
01.02.2018
Electrochemistry flushes out antibiotic-resistant proteins
Electrochemistry flushes out antibiotic-resistant proteins
EPFL scientists, working in association with Valais Hospital in Sion and Fudan University in Shanghai, have developed a method for analyzing bacteria that - for the first time ever - lets doctors quickly see exactly which proteins are associated with antibiotic resistance. Some bacteria contain proteins that indicate resistance to antibiotics.
Medicine/Pharmacology - Psychology
01.02.2018
0.5 Percent of the Population Suffer from Severe Psychological Trauma
0.5 Percent of the Population Suffer from Severe Psychological Trauma
Post-traumatic stress disorder (PTSD) can sometimes occur in a particularly severe form, known as complex post-traumatic stress disorder.
Medicine/Pharmacology - Life Sciences
31.01.2018
Stealth Virus for Cancer Therapy
Stealth Virus for Cancer Therapy
Viruses have their own genetic material and can infect human cells in a very specific manner. They will then reproduce as directed by their own genes but using the resources of the host cell.
Medicine/Pharmacology
30.01.2018
Epidemics: the end of containment measures?
Limiting population movements during an epidemic outbreak may not always be the best approach. This type of response may adversely affect a society's ability to resume functioning normally, according to an EPFL study. When an epidemic outbreak - such as those caused by the H1N1, Zika or SARS viruses - takes place, containment measures may seem to be the most reasonable solution.
Life Sciences - Medicine/Pharmacology
25.01.2018
Leprosy's drug resistance and origin revealed by genome analysis
Leprosy's drug resistance and origin revealed by genome analysis
Scientists led by EPFL have isolated leprosy bacteria directly from human samples, and analyzed the purified genomes to identify mutations that confer drug resistance to the bacterium, as well as gain insights into the origins of the disease. The study is published , just ahead of the World Leprosy Day , 28th January 2018.
Medicine/Pharmacology - Life Sciences
24.01.2018
Unexpected Helpers in Wound Healing
Unexpected Helpers in Wound Healing
An essential step in skin wound healing is wound closure, which is why shortly after an injury occurs, blood coagulates and seals the wound.
Medicine/Pharmacology - Life Sciences
24.01.2018
Boosting cancer therapy with cross-dressed immune cells
Boosting cancer therapy with cross-dressed immune cells
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors.
Medicine/Pharmacology - Agronomy/Food Science
17.01.2018
Medicine/Pharmacology - Agronomy/Food Science
17.01.2018
Bile acids fire up fat-burning
EPFL scientists have discovered a novel role for bile acids: converting energy-storing white fat depots into energy-expending beige fat. The study is published. Obesity arises from an imbalance between energy intake and energy expenditure. As a result, current treatments try to decrease calorie intake and/or increase energy expenditure.
Medicine/Pharmacology - Life Sciences
12.01.2018
Medicine/Pharmacology - Life Sciences
09.01.2018
Cluster of Resistant Tuberculosis Pathogen Discovered
Cluster of Resistant Tuberculosis Pathogen Discovered
Resistant tuberculosis pathogens are a regular part of the day-to-day business at the Swiss National Center for Mycobacteria (NZM) at the University of Zurich. And yet, the Mycobacterium tuberculosis found in a Somali asylum seeker in the refugee center in Chiasso in February 2016 was extraordinary: “These bacteria exhibited a new combination of resistance mutations against four different antibiotics that had never before been described,” says Peter Keller, Head of Diagnostics at NZM, who identified the germ.
Medicine/Pharmacology - Life Sciences
09.01.2018
New Biomarkers Predict Outcome of Cancer Immunotherapy
New Biomarkers Predict Outcome of Cancer Immunotherapy
Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes targeted use of the immune system's normal function of regularly examining the body's tissue for pathogens and damages. Specific inhibitors are used to activate immune cells in a way that makes them identify cancer cells as foreign bodies and eliminate them.
Life Sciences - Medicine/Pharmacology
27.12.2017
Bacteria acquire resistance from competitors
Bacteria acquire resistance from competitors
Bacteria not only develop resistance to antibiotics, they also can pick it up from their rivals. In a recent publication in "Cell Reports", Researchers from the Biozentrum of the University of Basel have demonstrated that some bacteria inject a toxic cocktail into their competitors causing cell lysis and death.
Medicine/Pharmacology - Computer Science/Telecom
26.12.2017
Looking back at 2017 (1/2)
Coral reefs that can survive global warming, an expedition around Antarctica, a booster for genetic research, a personnal virtual heart, a National Center for Data Science... Some of the EPFL's research and milestones that marked the year 2017.
1 2 3 4 5 ... 16 Next »